Due to their central role in promoting DNA repair and facilitating the resistance of cancer cells to genotoxin treatment, the ATM-CHK2 kinases are excellent candidates for modulation by small molecules inhibitors for targeted cancer therapy. Here, ATM is linked to cancer.